IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RESTEGHINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.959
AS - Asia 1.684
NA - Nord America 1.568
SA - Sud America 150
AF - Africa 39
OC - Oceania 1
Totale 5.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.513
DE - Germania 974
CN - Cina 487
SG - Singapore 467
IT - Italia 299
GB - Regno Unito 249
BD - Bangladesh 220
VN - Vietnam 194
HK - Hong Kong 143
BR - Brasile 119
RU - Federazione Russa 104
SE - Svezia 100
FR - Francia 63
IN - India 58
NL - Olanda 49
CA - Canada 35
IE - Irlanda 30
FI - Finlandia 27
ID - Indonesia 20
DK - Danimarca 19
KR - Corea 16
UA - Ucraina 16
AR - Argentina 14
CI - Costa d'Avorio 14
IQ - Iraq 14
TR - Turchia 12
JP - Giappone 11
MX - Messico 11
ES - Italia 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
EG - Egitto 6
TW - Taiwan 6
PL - Polonia 5
AT - Austria 4
EC - Ecuador 4
JM - Giamaica 4
PH - Filippine 4
PY - Paraguay 4
BE - Belgio 3
CH - Svizzera 3
CO - Colombia 3
KZ - Kazakistan 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
PK - Pakistan 3
VE - Venezuela 3
DO - Repubblica Dominicana 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NP - Nepal 2
TH - Thailandia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
MD - Moldavia 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
YE - Yemen 1
Totale 5.401
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 899
Singapore 254
Ashburn 235
Southend 205
San Jose 122
Hong Kong 121
Chandler 117
Dallas 109
Santa Clara 81
Milan 79
Beijing 66
Ho Chi Minh City 59
Council Bluffs 53
New York 53
Hanoi 50
Los Angeles 48
Seattle 44
Princeton 42
Wilmington 37
Hefei 35
Guangzhou 34
Lauterbourg 31
Dublin 30
Buffalo 28
Fairfield 27
Munich 25
Rome 21
Bengaluru 20
Dearborn 20
Moscow 20
Des Moines 17
Nanjing 16
Shanghai 16
Grafing 15
Jinan 15
Abidjan 14
Boardman 14
Seoul 14
São Paulo 14
Ann Arbor 13
Cambridge 13
Da Nang 13
Naples 12
Tianjin 12
Houston 11
London 11
Shenzhen 11
Helsinki 10
Jakarta 10
Baghdad 9
Phoenix 9
Tokyo 9
Berlin 8
Cangzhou 8
Dong Ket 8
Orem 8
San Diego 8
Shenyang 8
Woodbridge 8
Campinas 7
Chicago 7
Denver 7
Haiphong 7
Quanzhou 7
Turku 7
Zhengzhou 7
Atlanta 6
Johannesburg 6
Montreal 6
Nuremberg 6
Redwood City 6
Rio de Janeiro 6
Turin 6
Bologna 5
Brooklyn 5
Changsha 5
Dhaka 5
Hangzhou 5
Istanbul 5
Nanchang 5
San Francisco 5
The Dalles 5
Toronto 5
Trieste 5
Wuhan 5
Biên Hòa 4
Boston 4
Cairo 4
Central District 4
Columbus 4
Jiaxing 4
Kent 4
Manchester 4
Ottawa 4
Pavia 4
Pescara 4
Salvador 4
Shijiazhuang 4
Taipei 4
Warsaw 4
Totale 3.510
Salva come PNG Salva come JPEG
Nome #
Big Data in Head and Neck Cancer 251
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract 240
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 236
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 235
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 222
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas : Translational analyses and clinical impact 220
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 220
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 214
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 213
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 213
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 201
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 196
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 187
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 187
Management of patients with skin adnexal carcinomas 183
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target? 177
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 174
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 172
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials 168
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 149
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 148
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 148
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 147
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 136
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 136
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 123
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 116
Systemic therapy in metastatic salivary gland carcinomas : a pathology-driven paradigm? 111
Systemic anticancer therapy during end of life in head and neck squamous cell carcinoma patients. A retrospective single center study 101
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions 71
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study 67
Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ 49
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 45
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 45
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era 42
The role of volumetry in sinonasal cancer response assessment to induction chemotherapy, results from two phase II non-randomized controlled prospective multicentric trials: SINTART-1 and SINTART-2 38
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy 35
Totale 5.616
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.486
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022174 19 5 6 7 13 5 7 9 31 23 3 46
2022/2023343 45 35 41 28 37 71 1 14 34 15 14 8
2023/2024784 4 19 10 7 77 19 129 104 62 110 125 118
2024/20251.042 114 128 94 124 60 36 32 69 48 69 71 197
2025/20262.537 212 130 222 132 193 135 348 92 214 167 357 335
Totale 5.616